Butyrolactol A potentiates caspofungin efficacy against resistant fungi via phospholipid flippase inhibition is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2025). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Canadian Institutes for Health Research
Grant: FDN148463
Canadian Institutes for Health Research
Grant: PJT190298
Canadian Institutes for Health Research
Grant: FDN-154288
Canadian Institutes for Health Research
Grant: FRN 143215
Canadian Institutes for Health Research
Grant: MOP-119391
Canadian Institutes for Health Research
Grant: PJT-156067
National Institutes of Health
Grant: R01CA231466
National Institutes of Health
Grant: AI39115-27
National Institutes of Health
Grant: AI050113-20
National Institutes of Health
Grant: AI170543-02
National Institutes of Health
Grant: AI172451-02
National Institutes of Health
Grant: AI133654-07
National Institutes of Health predoctoral fellowship
Grant: F31 AI150120
National Institutes of Health
Grant: AI053721-20
National Institutes of Health
Grant: R01AI127375
CIFAR program Fungal Kingdom: Threats & Opportunities
Grant: CF-0185
CIFAR program Fungal Kingdom: Threats & Opportunities
Grant: CF-0116
PREreview of "Butyrolactol A is a phospholipid flippase inhibitor that potentiates the bioactivity of caspofungin against resistant fungi"
PREreview of "Butyrolactol A is a phospholipid flippase inhibitor that potentiates the bioactivity of caspofungin against resistant fungi"